Thromboelastography in acute immunologic reactions: a prospective pilot study

Biomarkers of fibrinolysis are elevated during acute immunologic reactions (allergic reactions and angioedema), although it is unclear whether fibrinolysis is associated with disease severity. We investigated a possible association between maximum lysis (ML) measured by thromboelastography and the s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Research and practice in thrombosis and haemostasis 2024-05, Vol.8 (4), p.102425, Article 102425
Hauptverfasser: Kienbacher, Calvin Lukas, Schoergenhofer, Christian, Ruzicka, Gerhard, Grafeneder, Jürgen, Hufnagl, Christine, Jilma, Bernd, Schwameis, Michael, Herkner, Harald
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 4
container_start_page 102425
container_title Research and practice in thrombosis and haemostasis
container_volume 8
creator Kienbacher, Calvin Lukas
Schoergenhofer, Christian
Ruzicka, Gerhard
Grafeneder, Jürgen
Hufnagl, Christine
Jilma, Bernd
Schwameis, Michael
Herkner, Harald
description Biomarkers of fibrinolysis are elevated during acute immunologic reactions (allergic reactions and angioedema), although it is unclear whether fibrinolysis is associated with disease severity. We investigated a possible association between maximum lysis (ML) measured by thromboelastography and the severity of acute immunologic reactions. We recruited patients with acute immunologic reactions at a high-volume emergency department. Clinical disease severity at presentation and at the end of the emergency department stay was assessed using a 5-grade scale, ranging from local symptoms to cardiac arrest. We determined ML on admission by thromboelastography (ROTEM's extrinsic [EXTEM], and aprotinin [APTEM] tests), expressed as ML%. Hyperfibrinolysis was defined as an ML of >15% in EXTEM, which was reversed by adding aprotinin (APTEM). We used exact logistic regression to investigate an association between ML% and disease severity (grades 1 and 2 [mild] vs 3-5 [severe]) and between hyperfibrinolysis and disease severity. We included 31 patients (71% female; median age, 52 [IQR, 35-58] years; 10 [32%] with a severe reaction). ML% was higher in patients with severe symptoms (21 [IQR, 12-100] vs 10 [IQR, 4-17]). Logistic regression found a significant association between ML% and symptom severity (odds ratio, 1.07; 95% CI, 1.01-1.21; P = .003). Hyperfibrinolysis was detected in 6 patients and found to be associated with severe symptoms (odds ratio, 17.59; 95% CI, 1.52-991.09; P = .02). D-dimer, tryptase, and immunoglobulin E concentrations increased with the severity of immunologic reactions. ML, quantified by thromboelastography, is associated with the severity of acute immunologic reactions. •Acute immunologic reactions can lead to alterations in blood clotting.•We investigated these alterations in emergency department patients using thromboelastography.•The blood clots of patients with more severe immunologic reactions seem to be more unstable.•Thromboelastography might be helpful to identify patients who need to be monitored closely.
doi_str_mv 10.1016/j.rpth.2024.102425
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11225642</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2475037924001146</els_id><sourcerecordid>3076766197</sourcerecordid><originalsourceid>FETCH-LOGICAL-c337t-8024f876ed70d60b721981929e4c41e400085559a066d457cebb4ebed846e4d33</originalsourceid><addsrcrecordid>eNp9UU1LAzEUDKJoqf4BD7JHL61JNpvsiiAifoHiRc8hm7y2KbubNckW-u9NaZV6EQIveZk3mcwgdE7wlGDCr5ZT38fFlGLKUoMyWhygEWWimOBcVId7-xN0FsISY5ywaRXH6CQvK8FEVY7Q28fCu7Z20KgQ3dyrfrHObJcpPUTIbNsOnWvc3OrMg9LRui5cZyrrvQs9pPMKst42LmYhDmZ9io5mqglwtqtj9Pn48HH_PHl9f3q5v3ud6DwXcVImvbNScDACG45rQUlVkopWwDQjwJLWsiiKSmHODSuEhrpmUIMpGQdm8nyMbre8_VC3YDR00atG9t62yq-lU1b-vensQs7dShJCacEZTQyXOwbvvgYIUbY2aGga1YEbgsyx4IJzUokEpVuoTp8OHma_7xAsN1nIpdxkITdZyG0WaehiX-HvyI_zCXCzBUDyaWXBy6AtdBqM9clYaZz9j_8bKLacHQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3076766197</pqid></control><display><type>article</type><title>Thromboelastography in acute immunologic reactions: a prospective pilot study</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Kienbacher, Calvin Lukas ; Schoergenhofer, Christian ; Ruzicka, Gerhard ; Grafeneder, Jürgen ; Hufnagl, Christine ; Jilma, Bernd ; Schwameis, Michael ; Herkner, Harald</creator><creatorcontrib>Kienbacher, Calvin Lukas ; Schoergenhofer, Christian ; Ruzicka, Gerhard ; Grafeneder, Jürgen ; Hufnagl, Christine ; Jilma, Bernd ; Schwameis, Michael ; Herkner, Harald</creatorcontrib><description>Biomarkers of fibrinolysis are elevated during acute immunologic reactions (allergic reactions and angioedema), although it is unclear whether fibrinolysis is associated with disease severity. We investigated a possible association between maximum lysis (ML) measured by thromboelastography and the severity of acute immunologic reactions. We recruited patients with acute immunologic reactions at a high-volume emergency department. Clinical disease severity at presentation and at the end of the emergency department stay was assessed using a 5-grade scale, ranging from local symptoms to cardiac arrest. We determined ML on admission by thromboelastography (ROTEM's extrinsic [EXTEM], and aprotinin [APTEM] tests), expressed as ML%. Hyperfibrinolysis was defined as an ML of &gt;15% in EXTEM, which was reversed by adding aprotinin (APTEM). We used exact logistic regression to investigate an association between ML% and disease severity (grades 1 and 2 [mild] vs 3-5 [severe]) and between hyperfibrinolysis and disease severity. We included 31 patients (71% female; median age, 52 [IQR, 35-58] years; 10 [32%] with a severe reaction). ML% was higher in patients with severe symptoms (21 [IQR, 12-100] vs 10 [IQR, 4-17]). Logistic regression found a significant association between ML% and symptom severity (odds ratio, 1.07; 95% CI, 1.01-1.21; P = .003). Hyperfibrinolysis was detected in 6 patients and found to be associated with severe symptoms (odds ratio, 17.59; 95% CI, 1.52-991.09; P = .02). D-dimer, tryptase, and immunoglobulin E concentrations increased with the severity of immunologic reactions. ML, quantified by thromboelastography, is associated with the severity of acute immunologic reactions. •Acute immunologic reactions can lead to alterations in blood clotting.•We investigated these alterations in emergency department patients using thromboelastography.•The blood clots of patients with more severe immunologic reactions seem to be more unstable.•Thromboelastography might be helpful to identify patients who need to be monitored closely.</description><identifier>ISSN: 2475-0379</identifier><identifier>EISSN: 2475-0379</identifier><identifier>DOI: 10.1016/j.rpth.2024.102425</identifier><identifier>PMID: 38974798</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>blood coagulation ; fibrinolysis ; immunological models ; Original ; thromboelastography ; tissue plasminogen activator</subject><ispartof>Research and practice in thrombosis and haemostasis, 2024-05, Vol.8 (4), p.102425, Article 102425</ispartof><rights>2024 The Authors</rights><rights>2024 The Authors.</rights><rights>2024 The Authors 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c337t-8024f876ed70d60b721981929e4c41e400085559a066d457cebb4ebed846e4d33</cites><orcidid>0000-0003-0630-1253 ; 0000-0002-2286-1077</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11225642/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11225642/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38974798$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kienbacher, Calvin Lukas</creatorcontrib><creatorcontrib>Schoergenhofer, Christian</creatorcontrib><creatorcontrib>Ruzicka, Gerhard</creatorcontrib><creatorcontrib>Grafeneder, Jürgen</creatorcontrib><creatorcontrib>Hufnagl, Christine</creatorcontrib><creatorcontrib>Jilma, Bernd</creatorcontrib><creatorcontrib>Schwameis, Michael</creatorcontrib><creatorcontrib>Herkner, Harald</creatorcontrib><title>Thromboelastography in acute immunologic reactions: a prospective pilot study</title><title>Research and practice in thrombosis and haemostasis</title><addtitle>Res Pract Thromb Haemost</addtitle><description>Biomarkers of fibrinolysis are elevated during acute immunologic reactions (allergic reactions and angioedema), although it is unclear whether fibrinolysis is associated with disease severity. We investigated a possible association between maximum lysis (ML) measured by thromboelastography and the severity of acute immunologic reactions. We recruited patients with acute immunologic reactions at a high-volume emergency department. Clinical disease severity at presentation and at the end of the emergency department stay was assessed using a 5-grade scale, ranging from local symptoms to cardiac arrest. We determined ML on admission by thromboelastography (ROTEM's extrinsic [EXTEM], and aprotinin [APTEM] tests), expressed as ML%. Hyperfibrinolysis was defined as an ML of &gt;15% in EXTEM, which was reversed by adding aprotinin (APTEM). We used exact logistic regression to investigate an association between ML% and disease severity (grades 1 and 2 [mild] vs 3-5 [severe]) and between hyperfibrinolysis and disease severity. We included 31 patients (71% female; median age, 52 [IQR, 35-58] years; 10 [32%] with a severe reaction). ML% was higher in patients with severe symptoms (21 [IQR, 12-100] vs 10 [IQR, 4-17]). Logistic regression found a significant association between ML% and symptom severity (odds ratio, 1.07; 95% CI, 1.01-1.21; P = .003). Hyperfibrinolysis was detected in 6 patients and found to be associated with severe symptoms (odds ratio, 17.59; 95% CI, 1.52-991.09; P = .02). D-dimer, tryptase, and immunoglobulin E concentrations increased with the severity of immunologic reactions. ML, quantified by thromboelastography, is associated with the severity of acute immunologic reactions. •Acute immunologic reactions can lead to alterations in blood clotting.•We investigated these alterations in emergency department patients using thromboelastography.•The blood clots of patients with more severe immunologic reactions seem to be more unstable.•Thromboelastography might be helpful to identify patients who need to be monitored closely.</description><subject>blood coagulation</subject><subject>fibrinolysis</subject><subject>immunological models</subject><subject>Original</subject><subject>thromboelastography</subject><subject>tissue plasminogen activator</subject><issn>2475-0379</issn><issn>2475-0379</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9UU1LAzEUDKJoqf4BD7JHL61JNpvsiiAifoHiRc8hm7y2KbubNckW-u9NaZV6EQIveZk3mcwgdE7wlGDCr5ZT38fFlGLKUoMyWhygEWWimOBcVId7-xN0FsISY5ywaRXH6CQvK8FEVY7Q28fCu7Z20KgQ3dyrfrHObJcpPUTIbNsOnWvc3OrMg9LRui5cZyrrvQs9pPMKst42LmYhDmZ9io5mqglwtqtj9Pn48HH_PHl9f3q5v3ud6DwXcVImvbNScDACG45rQUlVkopWwDQjwJLWsiiKSmHODSuEhrpmUIMpGQdm8nyMbre8_VC3YDR00atG9t62yq-lU1b-vensQs7dShJCacEZTQyXOwbvvgYIUbY2aGga1YEbgsyx4IJzUokEpVuoTp8OHma_7xAsN1nIpdxkITdZyG0WaehiX-HvyI_zCXCzBUDyaWXBy6AtdBqM9clYaZz9j_8bKLacHQ</recordid><startdate>20240501</startdate><enddate>20240501</enddate><creator>Kienbacher, Calvin Lukas</creator><creator>Schoergenhofer, Christian</creator><creator>Ruzicka, Gerhard</creator><creator>Grafeneder, Jürgen</creator><creator>Hufnagl, Christine</creator><creator>Jilma, Bernd</creator><creator>Schwameis, Michael</creator><creator>Herkner, Harald</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0630-1253</orcidid><orcidid>https://orcid.org/0000-0002-2286-1077</orcidid></search><sort><creationdate>20240501</creationdate><title>Thromboelastography in acute immunologic reactions: a prospective pilot study</title><author>Kienbacher, Calvin Lukas ; Schoergenhofer, Christian ; Ruzicka, Gerhard ; Grafeneder, Jürgen ; Hufnagl, Christine ; Jilma, Bernd ; Schwameis, Michael ; Herkner, Harald</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c337t-8024f876ed70d60b721981929e4c41e400085559a066d457cebb4ebed846e4d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>blood coagulation</topic><topic>fibrinolysis</topic><topic>immunological models</topic><topic>Original</topic><topic>thromboelastography</topic><topic>tissue plasminogen activator</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kienbacher, Calvin Lukas</creatorcontrib><creatorcontrib>Schoergenhofer, Christian</creatorcontrib><creatorcontrib>Ruzicka, Gerhard</creatorcontrib><creatorcontrib>Grafeneder, Jürgen</creatorcontrib><creatorcontrib>Hufnagl, Christine</creatorcontrib><creatorcontrib>Jilma, Bernd</creatorcontrib><creatorcontrib>Schwameis, Michael</creatorcontrib><creatorcontrib>Herkner, Harald</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Research and practice in thrombosis and haemostasis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kienbacher, Calvin Lukas</au><au>Schoergenhofer, Christian</au><au>Ruzicka, Gerhard</au><au>Grafeneder, Jürgen</au><au>Hufnagl, Christine</au><au>Jilma, Bernd</au><au>Schwameis, Michael</au><au>Herkner, Harald</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thromboelastography in acute immunologic reactions: a prospective pilot study</atitle><jtitle>Research and practice in thrombosis and haemostasis</jtitle><addtitle>Res Pract Thromb Haemost</addtitle><date>2024-05-01</date><risdate>2024</risdate><volume>8</volume><issue>4</issue><spage>102425</spage><pages>102425-</pages><artnum>102425</artnum><issn>2475-0379</issn><eissn>2475-0379</eissn><abstract>Biomarkers of fibrinolysis are elevated during acute immunologic reactions (allergic reactions and angioedema), although it is unclear whether fibrinolysis is associated with disease severity. We investigated a possible association between maximum lysis (ML) measured by thromboelastography and the severity of acute immunologic reactions. We recruited patients with acute immunologic reactions at a high-volume emergency department. Clinical disease severity at presentation and at the end of the emergency department stay was assessed using a 5-grade scale, ranging from local symptoms to cardiac arrest. We determined ML on admission by thromboelastography (ROTEM's extrinsic [EXTEM], and aprotinin [APTEM] tests), expressed as ML%. Hyperfibrinolysis was defined as an ML of &gt;15% in EXTEM, which was reversed by adding aprotinin (APTEM). We used exact logistic regression to investigate an association between ML% and disease severity (grades 1 and 2 [mild] vs 3-5 [severe]) and between hyperfibrinolysis and disease severity. We included 31 patients (71% female; median age, 52 [IQR, 35-58] years; 10 [32%] with a severe reaction). ML% was higher in patients with severe symptoms (21 [IQR, 12-100] vs 10 [IQR, 4-17]). Logistic regression found a significant association between ML% and symptom severity (odds ratio, 1.07; 95% CI, 1.01-1.21; P = .003). Hyperfibrinolysis was detected in 6 patients and found to be associated with severe symptoms (odds ratio, 17.59; 95% CI, 1.52-991.09; P = .02). D-dimer, tryptase, and immunoglobulin E concentrations increased with the severity of immunologic reactions. ML, quantified by thromboelastography, is associated with the severity of acute immunologic reactions. •Acute immunologic reactions can lead to alterations in blood clotting.•We investigated these alterations in emergency department patients using thromboelastography.•The blood clots of patients with more severe immunologic reactions seem to be more unstable.•Thromboelastography might be helpful to identify patients who need to be monitored closely.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>38974798</pmid><doi>10.1016/j.rpth.2024.102425</doi><orcidid>https://orcid.org/0000-0003-0630-1253</orcidid><orcidid>https://orcid.org/0000-0002-2286-1077</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2475-0379
ispartof Research and practice in thrombosis and haemostasis, 2024-05, Vol.8 (4), p.102425, Article 102425
issn 2475-0379
2475-0379
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11225642
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects blood coagulation
fibrinolysis
immunological models
Original
thromboelastography
tissue plasminogen activator
title Thromboelastography in acute immunologic reactions: a prospective pilot study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T17%3A52%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thromboelastography%20in%20acute%20immunologic%20reactions:%20a%20prospective%20pilot%20study&rft.jtitle=Research%20and%20practice%20in%20thrombosis%20and%20haemostasis&rft.au=Kienbacher,%20Calvin%20Lukas&rft.date=2024-05-01&rft.volume=8&rft.issue=4&rft.spage=102425&rft.pages=102425-&rft.artnum=102425&rft.issn=2475-0379&rft.eissn=2475-0379&rft_id=info:doi/10.1016/j.rpth.2024.102425&rft_dat=%3Cproquest_pubme%3E3076766197%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3076766197&rft_id=info:pmid/38974798&rft_els_id=S2475037924001146&rfr_iscdi=true